In 2011, Lenhard et al. also found in a mixed cohort of ovarian cancer (n = 156) that patients with only LHCGR tumor positivity had improved OS compared to patients with only FSHR tumor positivity (p = 0.030) [17]. This evidence concerns the gene FSHR and neoplasm.